Ratings by Mizuho (Graig Suvannavejh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/23/2026 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2026 | EyePoint Inc. | EYPT | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/22/2026 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2026 | Verastem | VSTM | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/16/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2026 | Immuneering Corporation | IMRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/26/2026 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2026 | Belite Bio, Inc, ADR | BLTE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/22/2026 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2026 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2026 | Palvella Therapeutics | PVLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2026 | Immunocore Holdings | IMCR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/7/2026 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2026 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2026 | Tarsus Pharmaceuticals | TARS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/15/2026 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2026 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2026 | Terns Pharmaceuticals | TERN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/8/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2026 | LeonaBio | LONA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2026 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/2/2026 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2026 | Palvella Therapeutics | PVLA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/1/2026 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/30/2026 | Immix Biopharma, Inc. | IMMX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2026 | Immix Biopharma, Inc. | IMMX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2026 | Terns Pharmaceuticals | TERN | Downgrade | Neutral (Outperform) |
53.17 (52.95) |
-0.41% | Details | |
| 3/27/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2026 | Tarsus Pharmaceuticals | TARS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2026 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2026 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2026 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/9/2026 | EyePoint Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2026 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2026 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2026 | Belite Bio, Inc, ADR | BLTE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/19/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Immunocore Holdings | IMCR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/19/2026 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | EyePoint Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Belite Bio, Inc, ADR | BLTE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2026 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2026 | LeonaBio | LONA | Upgrade | Outperform (Neutral) |
4.39 (9.39) |
113.9% | Details | |
| 2/9/2026 | Immix Biopharma, Inc. | IMMX | New Coverage | Outperform (N/A) |
6.74 (11.09) |
64.54% | Details | |
| 2/2/2026 | EyePoint Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2026 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2026 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2026 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2026 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2026 | EyePoint Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2026 | Palvella Therapeutics | PVLA | New Coverage | Outperform (N/A) |
90.43 (151.04) |
67.02% | Details | |
| 1/5/2026 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2025 | Verastem | VSTM | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/19/2025 | Athira Pharma | ATHA | Maintain | Neutral (N/A) |
|
Details | ||
| 12/18/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | EyePoint Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | Erasca Inc | ERAS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2025 | Belite Bio, Inc, ADR | BLTE | Upgrade | Outperform (Neutral) |
154.02 (153.24) |
-0.51% | Details | |
| 12/1/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/1/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/28/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/19/2025 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2025 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2025 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2025 | Immunocore Holdings | IMCR | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2025 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Alector Inc. | ALEC | Downgrade | Neutral (Outperform) |
3.31 (1.64) |
-50.45% | Details | |
| 10/21/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/13/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/2/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/25/2025 | Immuneering Corporation | IMRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/25/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2025 | Adverum Biotechnologies | ADVM | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/19/2025 | Athira Pharma | ATHA | Maintain | Neutral (N/A) |
|
Details | ||
| 9/18/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2025 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2025 | BioXcel Therapeutics | BTAI | Maintain | Neutral (N/A) |
|
Details | ||
| 9/8/2025 | Kala Bio | KALA | New Coverage | Outperform (N/A) |
14.55 (2.05) |
-85.91% | Details | |
| 8/27/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | Immuneering Corporation | IMRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/21/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/18/2025 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/18/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2025 | Ideaya Biosciences | IDYA | Maintain | (N/A) |
|
Details | ||
| 7/29/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/28/2025 | Erasca Inc | ERAS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2025 | BioXcel Therapeutics | BTAI | Maintain | Neutral (N/A) |
|
Details | ||
| 7/28/2025 | Immunocore Holdings | IMCR | Maintain | Neutral (N/A) |
|
Details | ||
| 7/28/2025 | Alector Inc. | ALEC | Upgrade | Outperform (Neutral) |
1.76 (3.31) |
88.07% | Details | |
| 7/22/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/18/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/16/2025 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/2/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/1/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/25/2025 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/25/2025 | Adaptimmune Therapeutics plc | ADAP | Downgrade | Neutral (Outperform) |
0.25 (0.05) |
-80% | Details | |
| 6/25/2025 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/23/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/18/2025 | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2025 | Insmed | INSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/11/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2025 | Vigil Neuroscience Inc | VIGL | Downgrade | Neutral (Outperform) |
2.31 (8.05) |
248.48% | Details | |
| 5/21/2025 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/20/2025 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/15/2025 | Terns Pharmaceuticals | TERN | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/8/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2025 | Amylyx Pharmaceuticals inc. | AMLX | Upgrade | Outperform (Neutral) |
3.42 (18.38) |
437.43% | Details | |
| 4/7/2025 | Immunocore Holdings | IMCR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/1/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2025 | Adaptimmune Therapeutics plc | ADAP | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2025 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2025 | Intra-Cellular Therapies | ITCI | Downgrade | Neutral (Outperform) |
1.00 (131.87) |
13087% | Details | |
| 2/21/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2025 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/24/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2025 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2025 | Neumora Therapeutics | NMRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/31/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/19/2024 | Corvus Pharmaceuticals | CRVS | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/18/2024 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/17/2024 | Alector Inc. | ALEC | Downgrade | Neutral (Outperform) |
1.97 (1.64) |
-16.75% | Details | |
| 12/16/2024 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/3/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2024 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/27/2024 | Adaptimmune Therapeutics plc | ADAP | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Immuneering Corporation | IMRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/25/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2024 | BioXcel Therapeutics | BTAI | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/11/2024 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2024 | Immunocore Holdings | IMCR | Downgrade | Neutral (Outperform) |
34.69 (33.08) |
-4.64% | Details | |
| 11/6/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2024 | Corvus Pharmaceuticals | CRVS | Upgrade | Outperform (Neutral) |
7.56 (16.20) |
114.29% | Details | |
| 10/18/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/10/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/4/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/3/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/3/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (Outperform) |
|
Details | ||
| 10/1/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/30/2024 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2024 | Ideaya Biosciences | IDYA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/23/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/23/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/23/2024 | BioXcel Therapeutics | BTAI | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/23/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 9/20/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/20/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/19/2024 | Immatics | IMTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/19/2024 | Neumora Therapeutics | NMRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/19/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/19/2024 | Athira Pharma | ATHA | Downgrade | Neutral (Outperform) |
0.49 (6.75) |
1277.55% | Details | |
| 9/16/2024 | Immuneering Corporation | IMRX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/16/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/13/2024 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/13/2024 | Immatics | IMTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/12/2024 | Neumora Therapeutics | NMRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/11/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/10/2024 | Terns Pharmaceuticals | TERN | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/9/2024 | Neumora Therapeutics | NMRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/9/2024 | BioXcel Therapeutics | BTAI | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/6/2024 | Neumora Therapeutics | NMRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/4/2024 | Athira Pharma | ATHA | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/27/2024 | Corbus Pharmaceuticals | CRBP | New Coverage | Outperform (N/A) |
59.25 (9.66) |
-83.7% | Details | |
| 8/21/2024 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2024 | Immuneering Corporation | IMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/16/2024 | Corvus Pharmaceuticals | CRVS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/15/2024 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2024 | BioXcel Therapeutics | BTAI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/12/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/29/2024 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/11/2024 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/8/2024 | Insmed | INSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/8/2024 | Ideaya Biosciences | IDYA | New Coverage | Outperform (N/A) |
34.26 (37.28) |
8.81% | Details | |
| 7/1/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 6/20/2024 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 6/7/2024 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/17/2024 | Adaptimmune Therapeutics plc | ADAP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2024 | Immatics | IMTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2024 | Insmed | INSM | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/13/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (Outperform) |
|
Details | ||
| 5/8/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/29/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2024 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 4/2/2024 | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/28/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2024 | Amylyx Pharmaceuticals inc. | AMLX | Downgrade | Neutral () |
3.17 (18.38) |
479.81% | Details | |
| 3/8/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/15/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/9/2024 | Verastem | VSTM | New Coverage | (N/A) |
13.45 (5.40) |
-59.85% | Details | |
| 2/9/2024 | Immuneering Corporation | IMRX | New Coverage | Outperform (N/A) |
6.09 (5.36) |
-11.99% | Details | |
| 2/9/2024 | Erasca Inc | ERAS | New Coverage | Outperform (N/A) |
1.76 (9.96) |
465.91% | Details | |
| 2/9/2024 | Corvus Pharmaceuticals | CRVS | New Coverage | Neutral (N/A) |
2.00 (7.56) |
278% | Details | |
| 2/9/2024 | Adaptimmune Therapeutics plc | ADAP | New Coverage | Outperform (N/A) |
1.15 (0.25) |
-78.26% | Details | |
| 2/6/2024 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/27/2023 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2023 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2023 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2023 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2023 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | (N/A) |
|
Details | ||
| 11/2/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Outperform (N/A) |
6.02 (14.84) |
146.51% | Details | |
| 11/2/2023 | Apellis Pharmaceuticals | APLS | New Coverage | Neutral (N/A) |
48.66 (41.03) |
-15.68% | Details | |
| 10/27/2023 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/19/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/19/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2023 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2023 | BioXcel Therapeutics | BTAI | Downgrade | Neutral (Outperform) |
4.33 (0.84) |
-80.6% | Details | |
| 8/11/2023 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | Vigil Neuroscience Inc | VIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Terns Pharmaceuticals | TERN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/22/2023 | Terns Pharmaceuticals | TERN | New Coverage | Outperform (N/A) |
11.74 (53.17) |
352.9% | Details | |
| 6/5/2023 | Rain Therapeutics | RAIN | Downgrade | Neutral (Outperform) |
1.11 (1.83) |
64.86% | Details | |
| 5/15/2023 | Athira Pharma | ATHA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2023 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/31/2023 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Outperform (N/A) |
29.19 (18.38) |
-37.03% | Details | |
| 3/31/2023 | Immunocore Holdings | IMCR | New Coverage | Outperform (N/A) |
47.86 (34.69) |
-27.52% | Details | |
| 3/31/2023 | Vigil Neuroscience Inc | VIGL | New Coverage | Outperform (N/A) |
10.40 (8.05) |
-22.6% | Details | |
| 3/31/2023 | Immatics | IMTX | New Coverage | Outperform (N/A) |
7.53 (9.96) |
32.27% | Details | |
| 3/29/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2023 | Rain Therapeutics | RAIN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2023 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2023 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2023 | Rain Therapeutics | RAIN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2023 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2023 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2023 | Rain Therapeutics | RAIN | New Coverage | Outperform (N/A) |
8.75 (1.83) |
-79.09% | Details | |
| 12/15/2022 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2022 | Insmed | INSM | New Coverage | Outperform (N/A) |
18.93 (118.26) |
524.72% | Details | |
| 11/16/2022 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2022 | BioXcel Therapeutics | BTAI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2022 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2022 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 9/7/2022 | Axsome Therapeutics | AXSM | New Coverage | Outperform (N/A) |
60.79 (248.95) |
309.52% | Details | |
| 8/23/2022 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2022 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2022 | Cerevel Therapeutics | CERE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/8/2022 | Alector Inc. | ALEC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2022 | Intra-Cellular Therapies | ITCI | New Coverage | Outperform (N/A) |
57.09 (1.00) |
-98.25% | Details | |
| 7/7/2022 | BioXcel Therapeutics | BTAI | New Coverage | Outperform (N/A) |
14.64 (0.84) |
-94.26% | Details | |
| 7/7/2022 | Athira Pharma | ATHA | New Coverage | Outperform (N/A) |
3.43 (0.49) |
-85.71% | Details | |
| 7/7/2022 | Cerevel Therapeutics | CERE | New Coverage | Neutral (N/A) |
30.63 (44.96) |
46.78% | Details | |
| 7/7/2022 | Alector Inc. | ALEC | New Coverage | Outperform (N/A) |
11.64 (1.64) |
-85.91% | Details | |
| 7/7/2022 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Outperform (N/A) |
52.65 (38.21) |
-27.43% | Details |
